Oruka posts Phase 2 win in psoriasis, hoping to compete with Skyrizi

April 27, 2026 10:19 AM EDT R&D Oru­ka posts Phase 2 win in pso­ri­a­sis, hop­ing to com­pete with Skyrizi Max Gelman Senior Editor Oru­ka Ther­a­peu­tics’ Phase 2 pso­ri­a­sis da­ta could mean there’s a fu­ture chal­lenger to megablock­buster Skyrizi. The com­pa­ny said on Mon­day that 40 of 63 pa­tients … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER